Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases.
Rios-Fernández
R
R
Gutierrez-Salmerón
M T
MT
Callejas-Rubio
J-L
JL
Fernández-Pugnaire
M
M
Ortego-Centeno
N
N
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D010392:Pemphigus / Q000150:complications* / Q000188:drug therapy; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab